Why is Nvidia’s market cap hitting $4 trillion?
How will Trump’s Brazil tariffs impact US prices?
What caused Ford’s massive US vehicle recall?
Why is Tesla expanding Robotaxi service in Phoenix?
How did Delta restore its profit outlook?
What’s behind Indeed and Glassdoor job cuts?
Why is Amazon considering more investment in Anthropic?
Ultragenyx, Mereo Shares Dive As Brittle Bone Disease Drug Misses Early Win
benzinga.com/news/health-care/25/07/46344208/ultragenyx-mereo-shares-dive-as-brittle-bone-disease-drug-misses-early-win
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO) stocks are plunging on Thursday.
What Happened?
The companies on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in…
This story appeared on benzinga.com, 2025-07-10 14:06:42.